3 reports

It affects one in approximately ##, ## live births.

  • Pathology
  • United States
  • Forecast
  • Market Size
  • Santhera Pharmaceuticals Holding AG
  • IDEBENONE - DRUG PROFILE

The company reported that subjects were randomized ##:##:## into one of three ophthalmic solution treatment groups: SkQ## ##. ## microgram/ mL, SkQ## ##. ## microgram/ mL, or ##. ## microgram/ mL (placebo).

  • Neurology
  • Pathology
  • Therapy
  • Type 2 Diabetes
  • Santhera Pharmaceuticals Holding AG
  • IDEBENONE - DRUG PROFILE

It is a small molecule which acts by controlling the oxidative and redox pathologies responsible for defects in mitochondria.

  • Pathology
  • Therapy
  • United States
  • Company Operations
  • Santhera Pharmaceuticals Holding AG